Meeting
2021 ASCO Annual Meeting
Association of plasma adiponectin with tumor infiltrating lymphocytes and survival in patients with stage III colon cancer (NCCTG N0147; Alliance).
Authors
Frank A. Sinicrope
Mayo Clinic, Rochester, MN
Frank A. Sinicrope , Qian Shi , Thomas C. Smyrk , Richard M. Goldberg , Steven J. Cohen , Sharlene Gill , Morton S. Kahlenberg , Suresh Nair , Anthony Frank Shields , Balkrishna N. Jahagirdar , Sawyer B. Jacobson , Nathan R. Foster , Michael N. Pollak , Steven R Alberts
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3591)
DOI
10.1200/JCO.2021.39.15_suppl.3591
Abstract #
3591
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Association of prognostic value of primary tumor location in stage III colon cancer with RAS and BRAF mutational status.
First Author: Julien Taieb
Poster
2023 ASCO Annual Meeting
A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.
First Author: Rona Yaeger
Poster
2015 ASCO Annual Meeting
Relationship between metformin use and recurrence and survival in patients (pts) with resected stage III colon cancer (CC) receiving adjuvant chemotherapy: Results from NCCTG N0147 (Alliance).
First Author: Preet Paul Singh
Poster
2021 ASCO Annual Meeting
Prognostic value of baseline and early changes of circulating-free (cf) and circulating tumor (ct) DNA in the neoadjuvant (NA) setting of early stage colon cancer (CC).
First Author: Giacomo Bregni